Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

Fintel reports that on January 27, 2025, Morgan Stanley downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 449.14% ...

Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But ...

DeepSeek was tasked with selecting two stocks investors can buy now and hold long-term due to their growth potential.